Jiuzhou Pharmaceutical (603456.SH) obtained the Approval Notice for the Market Application of Hydrobromic Acid Venlafaxine "Chemical Raw Materials Drug".

Zhixin Finance APP News, Jiuzhou Pharmaceutical (603456.SH) announced that the company recently received the "Notice of Approval for Listing Application of Chemical Raw Materials" (Notice No.: 2025YS00368) issued by the National Medical Products Administration (hereinafter referred to as "NMPA") for Hydrobromic Fluoxetine. Hydrobromic Fluoxetine is mainly used for the treatment of major depressive disorder (MDD) in adults.